Browsing by Author "Apichaya Junyavoraluk"

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • No Thumbnail Available
    PublicationMetadata only
    Immediate aortic dissection after transcatheter aortic valve replacement: A case report and review of the literature
    (2021-07-01) Pongprueth Rujirachun; Apichaya Junyavoraluk; Decho Jakrapanichakul; Nattawut Wongpraparut; Narathip Chunhamaneewat; Adisak Maneesai; Pranya Sakiyalak; Siriraj Hospital; Faculty of Medicine, Khon Kaen University
    -Aortic dissection of descending aorta was detected by intraoperative TEE in a case of 67-year-old man with symptomatic severe aortic stenosis after TAVR. -Transesophageal echocardiogram after TAVR procedure is helpful to detect this rare complication.
  • No Thumbnail Available
    PublicationMetadata only
    Leukemic arthritis and severe hypercalcemia in a man with chronic myeloid leukemia: A case report and review of the literature
    (2018-09-10) Pongprueth Rujirachun; Apichaya Junyavoraluk; Weerapat Owattanapanich; Voraparee Suvannarerg; Sirinart Sirinvaravong; Mahidol University; Faculty of Medicine, Siriraj Hospital, Mahidol University
    © 2018 The Author(s). Background: Patients with chronic myeloid leukemia typically present with high white blood cell counts revealed during annual checkups. Leukemic arthritis and hypercalcemia are rare manifestations in patients with chronic myeloid leukemia. Case presentation: A 35-year-old Thai man who had been diagnosed with chronic myeloid leukemia in the chronic phase developed blast crisis while he was receiving ongoing treatment with imatinib at 400 mg/day. Initially, he presented with oligoarthritis in both knees and ankles. A bone scintigraphy showed a prominent bony uptake, with a symmetrical, increased uptake in many bone areas. Induction therapy with a 7 + 3 induction regimen was prescribed in conjunction with 600 mg of imatinib once daily before switching to 140 mg of dasatinib. He subsequently developed severe hypercalcemia (total serum calcium of 17.8 mg/dL), with generalized osteolytic lesions detected on a bone survey. His serum vitamin D level was 50.64 ng/mL, while the serum parathyroid hormone level was 9.82 pg/mL. Despite the administration of an aggressive intravenously administered hydration, intravenously administered calcitonin, and 600 mg/day of imatinib, the severe hypercalcemia was refractory. We therefore decided to prescribe 20 mg/day of intravenously administered dexamethasone; fortunately, his serum calcium level decreased dramatically to normal range within a few days. Conclusions: Although leukemic arthritis and severe hypercalcemia are extraordinary presentations in patients with chronic myeloid leukemia, the advanced phase of the disease might bring on these symptoms. Apart from parathyroid hormone-related protein-related hypercalcemia, vitamin D is a mechanism of humoral-mediated hypercalcemia.
  • No Thumbnail Available
    PublicationMetadata only
    Successful treatment of arrhythmia with β-blocker and flecainide combination in pregnant patients with Andersen–Tawil syndrome: A case report and literature review
    (2020-01-01) Pongprueth Rujirachun; Apichaya Junyavoraluk; Manop Pithukpakorn; Bhoom Suktitipat; Arjbordin Winijkul; Mahidol University; Faculty of Medicine, Siriraj Hospital, Mahidol University
    © 2020 The Authors. Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC. Andersen–Tawil syndrome (ATS) is a rare disorder characterized by a triad of ventricular arrhythmia (VA), dysmorphic features, and periodic paralysis. Due to the rarity of this condition, less is known about physiologic effect of pregnancy to ATS and arrhythmia. There is no established guideline for peripartum or postpartum treatment and prevention of arrhythmia in ATS; thus, the clinical management is challenging. We reported two KCNJ2-associated ATS patients who got pregnant and underwent vaginal birth safely. Both individuals had VA, micrognathia without periodic paralysis. β-blocker plus flecainide could be an effective treatment combination when monotherapy failed to control arrhythmia. VA of two pregnant patients with ATS could be controlled by either physiologic changes associated pregnancy or the combination treatment of β-blocker and flecainide.